Mark Bach
Equibles does not estimate personal net worth.
Get an email with a short summary when Ascendis Pharma A/S publishes a filing, an earnings call transcript or a press release.
Get ASND alertsAbout Mark Bach
The proxy statement of Structure Therapeutics Inc. reports total compensation of $672,057 for Mark Bach in fiscal 2023, including a base salary of $485,812. Disclosed compensation is on record for 2 fiscal years. Ascendis Pharma A/S is classified in the Biotechnology industry within the Healthcare sector.
Affiliation history
-
Ascendis Pharma A/S (ASND)
Source not stated
Current -
Structure Therapeutics Inc. (GPCR)
Proxy statement
Start not stated–2024-04-25
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Structure Therapeutics Inc. (GPCR) | M.D., Ph.D. Chief Medical Officer | $485,812 | $672,057 |
| 2022 | Structure Therapeutics Inc. (GPCR) | M.D., Ph.D. Chief Medical Officer | $466,375 | $628,374 |
Recent activity
No call appearances or filed executive changes recorded yet.